Enanta Pharmaceuticals Rings the Closing Bell

About This Event

Enanta Pharmaceuticals, Inc. (Nasdaq: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, visits the Nasdaq MarketSite in Times Square to celebrate its 10-year anniversary of its Initial Public Offering.

In honor of the occasion, Jay R. Luly, Ph.D., President, Chief Executive Officer and Director, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore